Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study | Zendy

Jolyce Bourgeois | Zendy; Monique Elseviers | Zendy; Luc Van Bortel | Zendy; Mirko Petrović | Zendy; Robert Vander Stichele | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study

Author(s) -

Jolyce Bourgeois,

Monique Elseviers,

Luc Van Bortel,

Mirko Petrović,

Robert Vander Stichele

Publication year - 2014

Publication title -

european journal of clinical pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.845

H-Index - 108

eISSN - 1432-1041

pISSN - 0031-6970

DOI - 10.1007/s00228-014-1725-7

Subject(s) - discontinuation , medicine , quality of life (healthcare) , pittsburgh sleep quality index , benzodiazepine , nursing homes , insomnia , physical therapy , psychiatry , nursing , sleep quality , receptor

Guidelines discourage chronic benzodiazepines and related Z drugs (BZD/Zs) for sleep problems. However, prevalence among nursing home residents remains high. Discontinuing these drugs is widely recommended but seems difficult to implement. The aim of our study was to evaluate the overall feasibility in the nursing home, in terms of willingness towards discontinuation and success rate at 8 months, together with the impact on withdrawal symptoms, change in sleep quality, quality of life and medication use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research